EVER Pharma Jena GmbH Oncomed manufacturing a.s.
PolandAll drugs from this manufacturer
-
The medicine is intended for adults with advanced breast cancer or metastatic breast cancer (after other therapies have ceased to be effective). It is also used in the treatment of advanced liposarcoma or metastatic liposarcoma, when other treatment methods have proven ineffective.
Dosage form: solution for injection
Active substance Dosage eribulin 0.44 mg/ml ATC: L01XX41